FDA NDC Directory · JSON-LD · Markdown

KEPIVANCE

NDC 66658-113 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namepalifermin
Labeler / ManufacturerSwedish Orphan Biovitrum AB (publ)
Marketing categoryBiologic License Application · App BLA125103
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsPALIFERMIN (5.16 mg/1.2mL)
Marketing started20230804
Package count1

External sources

Source: openFDA. Public-domain (CC0).